Intel's stock is having its worst week since 2020. Is the selloff justified?
By Emily Bary
Intel's projection for steepening foundry losses this year after a $7 billion operating loss last year is 'somewhat breathtaking,' one analyst says
Intel Corp. offered more transparency around its business units earlier this week, but investors didn't seem to like what they saw.
While Wall Street largely expected the economics of Intel's foundry business to be bad, the chip maker appears to have surprised people with the magnitude of the weakness there when it broke out its manufacturing and product financials for the first time in a Tuesday afternoon update.
Don't miss: Intel's steep foundry losses aren't a surprise. Why its stock is still sliding.
The foundry business had a $7 billion operating loss last year, translating to a negative 37% operating margin. Intel (INTC) expects losses for the segment to peak this year.
"[T]he idea that things are still getting worse in 2024 might have beentaken somewhat poorly; if anything the idea that a -37% operating margin and $7 [billion] loss do not yet represent a trough is somewhat breathtaking especially given all the cost cuts the company was supposedly implementing last year," Bernstein's Stacy Rasgon wrote in a note to clients Friday.
Intel's stock is down 2.3% in afternoon trading Friday, even as the S&P 500 SPX and PHLX Semiconductor Index SOX are rallying. The stock is off 12.2% so far this week, putting on track for its worst weekly percentage drop since the week ending July 24, 2020, according to Dow Jones Market Data. The stock fell 15.7% that week.
Investors also appear disappointed that Intel is moving its goalposts, according to Rasgon, who flagged that the company pushed out its timeline for achieving 60% gross margins and 40% operating margins. Intel now expects that to occur in 2030, not 2026.
"We understand that given the situation pain was likely inevitable, and also recognize that investors are not necessarily the only audience for acompany's pronouncements. And maybe now expectations are getting to where they need to be," Rasgon wrote. "But it does seem that some of the turmoil could have been avoided (or at least muted) by taking a more realistic stance on things from the start."
He began that section of his note with the heading: "Why do they do this to themselves?"
Rasgon rates the stock at market perform with a $42 target price.
Mizuho desk-based analyst Jordan Klein said in a late Thursday note that Intel shares are in the "penalty box" with investors. There's "more worry that the targets for [gross-margin] improvement may be too aggressive and any slip or weak reaction to new server CPU products [may] create a big downside risk," he wrote, referring to central processing units.
Long-only investors are "highly skeptical" of the story, in his view, while hedge funds are "losing confidence quickly."
Read: Why this AMD bull is keeping the faith in the face of the stock's weakness
-Emily Bary
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-05-24 1323ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track